AWGLSCP
ABG-WTT Global Life Science Capital Partners’s Pulmonx LUNG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,204
| Closed | -$405K | – | 4 |
|
|
2025
Q1 | $405K | Hold |
60,204
| – | – | 1.06% | 4 |
|
|
2024
Q4 | $409K | Hold |
60,204
| – | – | 0.94% | 4 |
|
|
2024
Q3 | $499K | Hold |
60,204
| – | – | 2.48% | 3 |
|
|
2024
Q2 | $382K | Hold |
60,204
| – | – | 1.27% | 3 |
|
|
2024
Q1 | $558K | Hold |
60,204
| – | – | 1.34% | 3 |
|
|
2023
Q4 | $768K | Hold |
60,204
| – | – | 1.5% | 4 |
|
|
2023
Q3 | $622K | Hold |
60,204
| – | – | 2.98% | 4 |
|
|
2023
Q2 | $789K | Hold |
60,204
| – | – | 14.32% | 3 |
|
|
2023
Q1 | $673K | Hold |
60,204
| – | – | 10.62% | 3 |
|
|
2022
Q4 | $508K | Hold |
60,204
| – | – | 8.2% | 3 |
|
|
2022
Q3 | $1M | Hold |
60,204
| – | – | 6.26% | 3 |
|
|
2022
Q2 | $886K | Hold |
60,204
| – | – | 3.13% | 3 |
|
|
2022
Q1 | $1.49M | Hold |
60,204
| – | – | 12.13% | 3 |
|
|
2021
Q4 | $1.93M | Sell |
60,204
-33,627
| -36% | -$1.08M | 26.2% | 2 |
|
|
2021
Q3 | $3.38M | Hold |
93,831
| – | – | 22.93% | 2 |
|
|
2021
Q2 | $4.14M | Sell |
93,831
-721,188
| -88% | -$31.8M | 8% | 2 |
|
|
2021
Q1 | $37.3M | Hold |
815,019
| – | – | 40.66% | 2 |
|
|
2020
Q4 | $56.3M | Buy |
+815,019
| New | +$56.3M | 49.03% | 2 |
|